About this trial
This study aimed to investigate the feasibility of repetitive transcranial magnetic stimulation (rTMS) on the occipital lobe in patients with Lewy body dementia.
This is a proof-of-concept study to evaluate the safety and effect of occipital lobe stimulation in patients with Lewy body dementia. Over a period of two weeks, participants will receive rTMS to the primary visual cortex three times a week during visits. For the remaining 10 weeks, maintenance therapy will be administered with rTMS once a week during visits. Efficacy assessments will be conducted on the day of the final stimulation session and again four weeks later.
Eligibility criteria
Qualifiers
Over 65 years of age
Meeting the criteria for Probable DLB as proposed in the 2017 DLB diagnostic criteria
Scoring between 0.5 and 1 on the Clinical Dementia Rating Scale (CDR)
Disqualifiers
If other causes of cognitive impairment are suspected, such as neurosyphilis, hypothyroidism, hyperthyroidism, metabolic encephalopathy, brain tumor, acute cerebral hemorrhage, acute cerebral infarction, previous territorial or strategic cerebral infarction, Wernicke's encephalopathy, or severe white matter hyperintensity detected in hematological tests, brain MRI, etc.
If cooperation for interviews and self-assessment is difficult (e.g., due to hearing impairment, language disorders, severe psychotic conditions)
If there is a history of psychiatric disorders: major affective disorder, schizophrenia, or schizo-affective disorder
If electroencephalography (EEG) cannot be performed
Trial design
Treatments tested in this trial
- repetitive transcranial magnetic stimulation